Shares of pSivida Corp. (NASDAQ:PSDV) traded down 2% during mid-day trading on Friday . The company traded as low as $3.33 and last traded at $3.43, with a volume of 90,543 shares traded. The stock had previously closed at $3.50.

Separately, FBR & Co reiterated a “buy” rating and issued a $7.00 price target on shares of pSivida Corp. in a research report on Thursday, June 23rd. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $7.00.

The company’s market capitalization is $117.21 million. The firm’s 50-day moving average is $3.23 and its 200 day moving average is $3.15.

pSivida Corp. (NASDAQ:PSDV) last posted its quarterly earnings results on Thursday, May 5th. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.05. On average, equities analysts anticipate that pSivida Corp. will post ($0.62) EPS for the current year.

pSivida Corp. is a biotechnology company, which is engaged in the development of sustained-release drug-delivery products for treating eye diseases. The Company offers products for treatment of back-of-the-eye diseases. The Company’s lead development product, Medidur is used for posterior of the eye (posterior uveitis).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.